Hjem › Osteosarkom › Ohio
Kliniske studier for Osteosarkom i Ohio
12 studier for Osteosarkom søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 2
Alder 12 til 39 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT04616560Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Nationwide Children's Hospital, Columbus
RekruttererFase 1/2
Alder 12 til 40 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07725380Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- og 4 flere
RekruttererFase 3
Opp til 50 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT05235165Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119SPEARHEAD-3 Pediatric Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
Alder 2 til 21 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05642455Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT05210374Musculoskeletal Cancers Remote Monitoring and Care
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07129226NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
Opp til 30 år · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06239272Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT01790152A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- The Ohio State University Wexner Medical Center, Columbus
Rekrutterer
Alder 13 og eldre · Alle kjønn · Oppdatert 6. feb. 2026 · NCT06387485A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
18 Months – 40 Years · Alle kjønn · Oppdatert 12. aug. 2025 · NCT05135975Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
- UH Rainbow Babies & Children's Hospital, Cleveland
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 10. apr. 2025 · NCT05588648Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.